S. Reis-Alves

发表

The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns

K. Metze, I. Lorand-Metze, Helaine M Milanez, 2011, BMC infectious diseases.

The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes.

K. Metze, F. Traina, I. Lorand-Metze, 2010, Neoplasma.

The World Health Organisation classification of myelodysplastic syndromes contains prognostically relevant information beyond the prognostic scores IPSS-R or WPSS.

K. Metze, I. Lorand-Metze, S. Reis-Alves, 2017, European journal of cancer.

Umbilical cord blood CD34+ stem cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapy

S. T. Olalla Saad, K. Metze, I. Lorand-Metze, 2015, Vox sanguinis.

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores

K. Metze, F. Traina, I. Lorand-Metze, 2013, PloS one.

A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes

K. Metze, I. Lorand-Metze, S. Saad, 2020, Scientific Reports.

Presence of B‐cell precursors in bone marrow is a favorable independent prognostic factor for overall survival in patients with myelodysplastic syndromes

K. Metze, I. Lorand-Metze, S. Reis-Alves, 2016, American journal of hematology.

Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors

K. Metze, F. Traina, I. Lorand-Metze, 2015, Diagnostic Pathology.

Monocyte phenotypic aberrancies are an unfavorable prognostic factor in patients with myelodysplastic syndromes and low IPSS-R scores.

K. Metze, I. Lorand-Metze, S. Reis-Alves, 2016, Cellular immunology.